Amethyst House

specializing in addiction recovery

CALL TODAY

3610 N. Elm Street, Suite A Greensboro, NC 27455

336.674.9781

AMETHYSTCARES.COM

WELCOME Located in Greensboro, NC, Amethyst Consulting & Treatment Solutions is a privately owned and nationally accredited psychotherapy organization serving the middle section of the southeast, U.S. Our immediate service area includes Greensboro, High Point, Winston-Salem,

We provide a broad range of psychotherapy and counseling services to adults, adolescents, children, and their families. Our services address issues ofdepression, stress, anxiety, addiction, problem behaviors, trauma, and relational problems. Our goal is to provide you and your family with the most effective therapy services required to achieve optimal emotional and behavioral health

Because our committment is to treating and resolving behavioral and emotional distress, we strictly adhere to evidence-based, solution- focused psychotherapy treatment models. Our treatment addresses your problem within the environmental framework in which it occurs; be it home, work, school, family, or other relationships or settings.

Burlington, Yanceyville, Asheboro and beyond.

THE AMETHYST WAY Amethyst Consulting & Treatment Solutions, PLLC was born of more than 20 years of providing professional clinical services; including psychotherapy services for adults, adolescents, children, and families as well as mental health-related training, research, and consultation to various clinical organizations. Over the years, we have evolved our own unique Vision, Mission, and culture of core Values that guide our professional calling. Functionally, our core Values are the framework and guiding principles by which we execute our Mission and reach for our Vision. Collectively, our Vision, Mission, and Core Values have come to characterize what we endearingly term “The Amethyst Way”.

OUR VISION We envision a society that values and promotes mental health as an integral part of overall health within and across diverse communities so that individuals and their families are free from stigma and discrimination and can successfully realize their potential. OUR MISSION Amethyst is committed to developing and providing the latest, most effective treatment practices and, in all things, promoting dignity, compassion, and respect for clients and their families as the absolute standard.

OUR VALUES 1. Communicate With Compassion

“People don’t care how much we know until they know how much we care”; and every human encounter is our opportunity to show how much we care. It is our opportunity to connect, build trust, understand, and serve our clients, colleagues, and stakeholders. We listen actively and with compassion; and are careful to respond with kind words and acts of gratitude, both professionally and personally. We value the strong, trusting, and enduring relationships that result, because through them we can accomplish much more than we could otherwise. We practice compassion with the knowledge that it is the fuel that allows us to realize our professional purpose to serve and help others. 2. Earn Loyalty By Practicing Loyalty We practice steadfast allegiance to the Amethyst vision and mission with the understanding that both require loyal interdependent relationships among clients, colleagues, and stakeholders alike. At the agency level, we are willing to make an investment and personal sacrifice for the good of the organization. We internalize agency goals as personal and professional goals. We represent the Amethyst name, brand, and our colleagues positively to the greater community and actively consider what’s best for the organization on a whole; sometimes putting the company ahead of personal considerations. We show loyalty to our clients by remaining conscious of the humble truth that we exist as a profession only because of their willingness to entrust us with their needs. With that in mind, we never give up on them and the promise of their total restoration and recovery. We owe them our best effort. We promote loyalty with fellow colleagues and stakeholders when we give recognition for a job well done, offer a helping hand during their times of challenge, and actively support work/family balance. 3. Empower We promote an environment that allows clients to be actively involved in their care. We encourage self-trust to such a level that clients see and believe themselves to be the change agent, thus capable of making decisions about their own treatment. We promote their confidence that their decisions will help them effectively manage their clinical concerns. We promote an environment where partners and colleagues show initiative by taking on and completing tasks with only the amount of guidance required. We want others to feel good about stepping up and taking on a task with creativity and a certain degree of autonomy and responsibility for decision-making. 4. Cultural Competency We strive to understand culture as a component of human behavior, recognizing the strengths that exist in all cultures. We strive to interact effectively with people of different cultures and socio-economic backgrounds. We are committed to providing services tailored to the specific needs of each client, taking into account the importance of gender, ethnic, religious, racial, and socioeconomic differences. 5. Collaboration We work together to achieve our cause by drawing upon the perspectives, values, and experiences of our colleagues, other disciplines, professionals and stakeholders. We make good use of supervision and consultation. Team members take initiative when issues arise and collaborate with others to address them. Beyond that, we watch out for each other and care for each other. We work together and never go it alone.

6. Embrace and Drive Change To quote Charles Darwin “It is not the strongest of the species that survive, nor the most intelligent, but the one most responsive to change.” We not only expect constant change, we embrace it. We are well aware that today’s professional healthcare environment is fast-paced and anything but static. We require change to maintain our competitive edge and to meet the needs of our clients and stakeholders. We never settle into a position of comfort but are always brainstorming and implementing ways to strengthen the efficiency of our systems and procedures. 7. Professional Development As an evidence-based practice, we view continuing education and learning as vital ingredients of quality services. We are aware that as our industry and profession change, continuing education and training are required in order to develop and provide the latest and most effective treatment practice. 8. Passion Driven Our passion for mental health and The Amethyst Way keeps us going. We believe in what we are doing and where we’re going. We see behavioral and emotional problems in our society through a psychotherapeutic lens and are positive and optimistic that the resolution of these problems lies in effective and accessible treatment. It is because of our passion that we are eager to educate the public, advocate for the vulnerable, and provide the most effective mental health treatment possible. 9. Integrity We are each personally accountable for the highest standards of professional behavior and ethics, including transparency, honesty, and fairness in all aspects of our work. We fulfill our commitments and are accountable for our actions, successes, and failures. We will consistently treat our clients, colleagues, stakeholders and company resources with the dignity, compassion, and respect they deserve. 10. Work Hard, Play Hard Because we believe in the dignity of hard work, as a rule, we do more than expected. We make the extra effort and never give up. It is easy for us to “do what needs to be done”, “go the extra mile”, and “make it happen” because our work is our passion. We set standards and examples of hard work for new and existing team members, knowing that this builds team spirit and produces better clinical outcomes. We are never satisfied with just enough. Because the challenge is great, having fun in the workplace is all the more important. A fun work environment boosts morale and encourages positive, energetic, and enthusiastic team members. We sponsor employee activities to strengthen relationships, celebrate successes, and to simply decompress. People don’t care how much we know until they know how much we care

Talkin’ ‘Bout My Generation

NIDA Researchers Develop Screening Tool for Teen Substance Use This article is a condensed version of a piece that originally appeared on the National Institute on Drug Abuse (NIDA) website.

Teens’ use of addictive substances often goes undetected by health care providers. But NIDA-supported researchers have developed a Brief Screener for Tobacco, Alcohol and other Drugs (BSTAD), to help spot teens’ problematic habits. In a recent study, BSTAD developers Dr. Sharon Kelly and colleagues at the Friends Research Institute in Baltimore examined the frequencies of use likely to qualify a teen for a diagnosis of an alcohol use disorder (AUD), nicotine use disorder (NUD), or cannabis use disorder (CUD). The frequencies proved to be surprisingly low, according to the researchers.

Teen drug substance use revealed For the study, the BSTAD survey employed a few, simple questions about teens’ use of alcohol, tobacco or drugs within the past year.The teens’ BSTAD responses revealed that 22 percent had used alcohol in the past year, 16 percent had used marijuana, 10 percent had used tobacco, and 3 percent had used at least one illicit substance other

than marijuana. (Original article by Eric Sarlin, M.Ed., M.A., NIDA Notes Contributing Writer) 28

“ Health care providers should have a one-on-one discussion with teens who indicate any substance use to assess level of risk, provide brief advice, and, if necessary, recommend further assessment for a treatment intervention. “

-Dr. Sharon Kelly, Friends Research Institute

Analysis of the data showed that almost all teens who reported on the BSTAD that they had consumed an alcoholic beverage on two or more days during the past year had an AUD. Conversely, teens who reported drinking on fewer than two days were unlikely to have this disorder.The corresponding BSTAD cut point for an NUD was nicotine use on two or more days during the past year and for a CUD was marijuana use on two or more days. BSTAD enables early detection Using these cut points, the researchers found that the BSTAD was highly sensitive. Ninety-six percent of teens with an AUD, 95 percent with an NUD, and 80 percent with a CUD would be flagged as likely in need of further assessment for a brief intervention or referral to treatment. BSTAD’s specificity was also high: 85 percent of teens without an AUD, 97 percent without an NUD, and 93 percent without a CUD reported use below the cut points, and so would be correctly classified. “Very low substance use frequencies were found to be optimal in identifying these disorders,” Dr. Kelly comments. The BSTAD does not distinguish

Researchers encourage regular screening Both the World Health Organization and the American Academy of Pediatrics recommend screening all adolescent patients for substance use since problems later in life often originate in adolescence. Still, many providers do not regularly screen their patients for substance abuse. “Providers are extremely busy and need a quick and valid screening measure for identifying teens who use substances,” says Dr. Kelly. She and colleagues developed the BSTAD in response to a NIDA call for new tools to fill this need. To create the BSTAD, Dr. Kelly and colleagues added the questions about tobacco and marijuana to the widely disseminated National Institute on Alcohol Abuse and Alcoholism screen for youth alcohol use. In the validation study, the FRI research team administered the BSTAD in person to half of the participants, and the rest of the participants self-administered the instrument on an iPad. The teens reported a strong preference for the iPad. The iPad version offers the potential extra convenience that results can be automatically transferred into a teen’s electronic medical record. 

the severities of the disorders, she notes, so when it flags a teen, providers need to follow up with questions to determine appropriate interventions or referrals to treatment. Furthermore, Dr. Kelly says, “Health care providers should have a one-on-one discussion with teens who indicate any substance use to assess level of risk, provide brief advice, and, if necessary, recommend further assessment for a treatment intervention.” Providers also should rescreen teens regularly, because onset of substance use can occur abruptly during adolescence. Pediatrics recommend screening all adolescent patients for substance use since problems later in life often originate in adolescence. Both the World Health Organization and the American Academy of

OUR VALUES

Communicate With Compassion

Collaboration

Empower

Earn Loyalty By Practicing Loyalty

C u l t u r a l Competency

Amethyst Consulting & Treatment Solutions, PLLC www.amethystcares.com • 336.674.9781 • 3610 N. Elm Street, Suite A • Greensboro, NC 27455

Professional Development

Integrity

Passion Driven

Embrace and Drive Change

Work Hard, Play Hard

SAMHSA PUBLISHES BEST PRACTICES ON MEDICATION-ASSISTED TREATMENT FOR OPIOID USE DISORDER Best Practices

Treatment Improvement Protocol 63, “Medications for Opioid Use Disorder,”

reviews the use of methadone, naltrexone, and

buprenorphine, the three FDA-approved medications to treat opioid use disorders.

Data indicate that OUD-treating medications are both cost effective and cost beneficial

The Substance Abuse and Mental Health Services Administration has published new guidance to help health care professionals better understand medications that can be used to treat Americans with opioid use disorder (OUD). Treatment Improvement Protocol (TIP) 63, “Medications for Opioid Use Disorder,” reviews the use of methadone, naltrexone, and buprenorphine, the three FDA-approved medications to treat opioid use disorders. TIP 63 provides guidance for health care professionals and addiction treatment providers on how to appropriately prescribe these medications and effectively support patients using these medications for OUD treatment. “We know that people can and do recover from opioid use disorders when they receive appropriate treatment, and medication-assisted treatment’s success in treating opioid use disorders is well documented,” said Dr. Elinore F. McCance-Katz, assistant secretary for Mental Health and Substance Use. “TIP 63 emphasizes that increasing access to medications to treat opioid use disorder will help more people recover, enabling them to improve their health, living full and productive lives.” TIP 63 is part of SAMHSA’s larger response to the opioid crisis. More access to treatment with OUD medications is critical to closing the gap between treatment need and treatment availability and an important public health strategy. Data indicate that OUD-treating medications are both cost effective and cost beneficial.

DO NOT SUFFER WITH DRUG ADDICTION AGAIN!

AMETHYST CONSULTING & TREATMENT SOLUTIONS, PLLC 3610 N Elm Street, Suite A Greensboro, NC 27455 336-674-9781 www.amethystcares.com

Therapy for Individuals, Couples, & Families

Dead people don’t get into recovery

D. Waters Is Suboxone a Reasonable Treatment Option for Opioid Addicts? After twenty years of providing substance abuse treatment I can tell you that the ultimate goal of anyone battling an addiction is total abstinence. Every addict and alcoholic eventually figures out they can not control their usage, and moderation is unrealistic. Learning to live life on life’s terms is part of the process of learning to live abstinent. Self-help programs like Alcoholics Anonymous(AA) and Narcotics Anonymous(NA) do a great job of helping people understand their addiction, themselves, and effective solutions for coping with their disease. Dead people don’t get into recovery Opioid addicts are not terribly different from any other addict or alcoholic, except the risk of death by accidental overdose is huge. People are dying in droves from opioid overdose. The current heroin epidemic is even more dangerous than the pain killer epidemic it replaced. Relapse rates are tremendous. Unfortunately, it may take years before an individual addict is ready to give the 12-Step AA/NA

I’ve truly never seen anything work better, and when it works it’s a beautiful thing.

process the thorough try it requires to be effective. Therefore, Suboxone is a terrific option for chronic relapsers. You can’t generally get high from it, unless you haven’t used in awhile, or never used in the first place. You can’t overdose on it from use or abuse, and any other opioid you take while it’s in your system will be nullified and wasted.

Not the solution, but maybe a good step forward Suboxone is not the solution, but in many cases it’s better than nothing, and a good response for chronic relapsers who are risking death from overdose. At least the addict is getting some exposure to treatment which is more likely to lead to recovery in the long run. Suboxone buys people time and keeps them alive. There are quite a few people who’s funerals I’ve attended that I wish had gotten on Suboxone. You can’t treat the dead.

The Subs knock down the monster cravings almost completely, and people don’t go through the nasty withdrawal that’s so painful. Once dysfunctional people who couldn’t hold a job, or were constantly on the obsessive hunt for the next fix suddenly become much more functional, and the addiction looks like it’s in remission. They can work consistently, they stop chasing the drugs, they have more money and can care for themselves and their families, and their addiction doesn’t seem to be ruling their lives. It seems like magic! Very few people actually wean off Suboxone successfully Suboxone users often wrongly think they’re cured because they look and feel more functional. Then they think all they have to do now is wean down, or taper off the medication, which is what the clinic doctors help them manage over a number of months to years. The problem is they’ve done nothing about the underlying addiction and all the addictive thinking and coping that go along with it that drive the addiction from within. They haven’t developed any social support, or learned anything about themselves and their disease. We like to say that using, or putting some chemical into the body, is only a symptom of the underlying disease. Abusing substances is not the actual disease—just a symptom. As soon as they stop using the Subs the addiction is still there and ready to start expressing itself all over again through the many painful ways it does. Chemically addicted people cope with life stressors with chemicals—that is, unless they make some fairly significant changes. Suboxone changes nothing in the end. Suboxone changes nothing A combination of Suboxone treatment coupled with AA/NA (with Sponsor and Step work) is a great thing. At Crossroads Counseling we require anyone with a substance abuse issue

to attend AA/NA, obtain a Sponsor, and work the 12-steps. If they don’t we won’t sign-off on their program. Most Suboxone clinics require their participants to attend at least one counseling meeting a month. Unfortunately, this is almost completely useless unless the individual engages in a personal program of recovery that addresses not only the biological issues, but the social, psychological, and spiritual issues related to the disease, as well.

MISSION Amethyst is committed to developing and providing the latest, most effective treatment practices and,

in all things, promoting dignity, compassion, and respect for clients and their families as the absolute standard.

WWW.AMETHYSTCARES.COM 336.674.9781 • 3610 N. ELM STREET, SUITE A • GREENSBORO, NC 27455

not just a bad habit It’s NOT JUSTA BAD HABIT

Recent research and dialogue in the political sphere have brought long-simmering questions about addiction to the forefront: Is addiction truly a disease? Do addicts deserve to be treated like people who have a Recent res arch and ialogue in the political spher have brought long-sim ering questions about ad iction to the fore: Is addiction truly a disease? Do addicts deserve to b tr ated like people who hav a dise s that’s outside their control? disease that’s outside their control? While most researchers agree with the so-called disease model of addiction, stereotypes and cultural bias continue to stigmatize those with addiction because they made an initial choice to consume substances. However, Columbia University researchers point out that “choice does not determine whether 34 While most res archers agre with the so-called isease model of ad iction, ster otypes and cultural bias continue to stigmatize those with ad iction because they made an initial choice to consume substances. However, Columbia University res archers point out that “choice does not det rmine whether

something is a disease. Heart disease, diabetes and some forms of cancer involve personal choices like diet, exercise, sun exposure, etc. A disease is what happens in the body as a result of those choices.” Experts say that applying the distinction of choice to addiction creates biases that justify inadequate treatment. It begs the question New Jersey Gov. Chris Christie asked during a 2015 town hall meeting in New Hampshire. When Christie’s mother was diagnosed something is a disease. Heart disease, diabet s and some forms of cancer involve personal choices like diet, exercise, sun exposure, etc. A disease is what hap ens in the body as a result of those choices.” Experts ay that ap lying the distinction of choice to ad iction creates biases that justify inadequate treatment. It begs the question New Jersey Gov. Chris Christie asked uring a 2015 town hall me ting in New Hampshire. When Christie’s mother was diagnosed with lung cancer at 71 as a result of addiction to tobacco, he noted that with lung cancer at 71 as a result of ad iction to tobacco, he noted that

no one suggested that she should not be treated because she was “getting what she deserved,” he said. “Yet somehow, if it’s heroin or cocaine or alcohol, we say, ‘Ahh, they decided that, they’re getting what they deserve,’” Christie remarked. HOW ADDICTION WORKS After satisfying basic human needs like food, water, sleep and safety, people feel pleasure. That pleasure is brought by chemical releases in the brain. This is according to Columbia researchers, who note that the disease of addiction causes the brain to release high levels of those pleasure chemicals. Over time, brain functions of reward, motivation and memory are altered. After these brain systems are compromised, those with addiction can experience intense cravings for substance use, even in the face of harmful consequences. These changes can stay in the brain long after substance use desists. The changes may leave those struggling with addiction to be vulnerable to “physical and environmental cues they associate with substance use, also known as triggers, which can increase their risk of relapse,” write Columbia researchers.

not just a bad habit treatment and continued monitoring and support or recovery.

THE COLUMBIA RESEARCHERS DO HAVE SOME GOOD NEWS: Even the most severe, chronic form of the disorder can be manageable and reversible, usually with long term

Feeling Down?

Don’t face opioid addiction alone. Get help today. www.amethystcares.com

our goal is to provide you and your family with the most effective therapy services required to achieve optimal emotional and behavioral health.

3610 N ELM STREET SUITE A • GREENSBORO, NC 27455 | PH: (336)674-9781

I N AN EFFORT to encourage new treatments for opioid addiction, the Food and Drug Administration plans to begin permitting pharmaceutical companies to sell medications that help temper cravings, even if they don’t fully stop addiction. The change is part of a wider effort to expand access to so-called medication-assisted treatment, or MAT. The agency will issue draft guidelines in the next few weeks. A senior agency official provided details of the proposal to The New York Times. the agency said it would soon publish two guidances, recommendations for drugmakers, on the issue.

The new approach was signaled Saturday by the health and human services secretary, Alex M. Azar II, in remarks to the National Governors Association. Mr. Azar said the agency intended “to correct a misconception that patients must achieve total abstinence in order for MAT to be considered effective.” While the Trump administration has generally supported medication-assisted treatment, Mr. Azar’s predecessor, Tom Price, was not completely on board with it. Mr. Price caused an uproar among treatment experts when he dismissed some medications that reduce cravings through synthetic opioids last spring as substituting one opioid for another. He subsequently walked back those comments, saying officials should be open to a broad range of treatment options. Mr. Azar, who took office late last month, said he would work to reduce the stigma associated with addiction and addiction therapy, and would not treat it as a moral failing. The opioid epidemic is considered the most unrelenting drug crisis in United States history. In 2016, roughly 64,000 people were killed by drug overdoses, including from prescription opioid painkillers and heroin. to correct a misconception that patients must achieve total abstinence in order for MAT to be considered effective. Noting federal data showing that only one-third of specialty substance abuse treatment programs offer medication-assisted treatment, Mr. Azar said, “We want to raise that number — in fact, it will be nigh impossible to turn the tide on this epidemic without doing so.” Mr. Azar’s comments echo those of the F.D.A. chief, Dr. Scott Gottlieb, who has made battling opioid abuse a priority for his agency. Dr. Gottlieb has moved to reduce opioid prescriptions by doctors and dentists and to promote more medication- assisted treatment, defined as drugs used to stabilize brain chemistry, reduce or block the euphoric effects of opioids, relieve physiological cravings, and normalize body functions. The F.D.A. has approved three drugs for opioid treatment — buprenorphine (often known by the brand name Suboxone), methadone and naltrexone (known by the brand name Vivitrol) — and says they are safe and effective combined with counseling and other support. But the agency said it would soon publish two guidances, recommendations for drugmakers, on the issue.

Our goal is to provide you and your familywith the most effective therapy services required toachieve optimal emotional and behavioral health.

Start the journeynow. The best is yet tocome. WWW.AMETHYSTCARES.COM 336.674.9781 • 3610 N. ELM STREET, SUITE A • GREENSBORO, NC 27455

The harsh reality is that opioids are killing thousands of people in this country, many of them young people

State legislators focused on opioid addiction treatment and prevention in schools and prisons Thursday while reviewing bills that would both use medications to thwart overdoses and assist in recovery. A bill making its way through the Legislature would require all schools with grades 9 to 12 to have policies for training nurses on how to administer naloxone. The schools would also have to keep a supply of the medication ready. “The harsh reality is that opioids are killing thousands of people in this country, many of them young people,” Assemblyman Vincent Mazzeo, D-Atlantic, bill sponsor, said in a statement. “Narcan has been proven to save lives. Having it readily available in schools can help ensure that our schools are ready to respond in every emergency situation.” Several South Jersey schools, including Millville, Mainland Regional High School, the Egg Harbor Township School District and the Ocean City School District, already have such policies in place. As of 2017, New Jersey ranked eighth in the nation for drug overdose deaths among people ages 12 to 25, according to the national nonprofit Trust for America’s Health. There have been an estimated 654 overdose deaths in New Jersey since Jan. 1, according to the Department of the Attorney General.

The bill would require that nurses be taught how to use the anti-opioid drug and have a prescription standing order for naloxone to keep it in supply. There were more than 14,300 uses of naloxone in the state last year, state data shows. If passed, the law would also provide immunity from liability for school nurses and other employees when an opioid reversal is performed. Nearby, members of the Assembly Health and Human Services Committee reviewed a bill sponsored by Assemblyman Herb Conaway, D-Burlington, that would require state correctional facilities to offer inmates naltrexone and naloxone just before their release. Naltrexone, known by its brand name Vivitrol, is a type of nonopioid medication- assisted treatment (MAT) for a substance-use disorder. Studies have shown medication-assisted treatments like naltrexone, methadone and buprenorphine have successfully been used to reduce relapse rates and help people maintain recovery from opioid addiction. Vivitrol completely blocks the euphoric and sedative effects of opioids. Recipients often need a monthly shot of the medication administered by a medical professional.

At John Brooks Recovery Centers in Atlantic City and Pleasantville, Vivitrol is just one medication-assisted treatment offered to inpatient and outpatient patients, but it is coupled with counseling and other treatment education. Alan Oberman, CEO of John Brooks Recovery Center, said that while the bill looks well intentioned, giving one shot of Vivitrol, which costs about $1,000, to an outgoing inmate without follow-up or counseling only buys that person about three or four weeks of sobriety before they may use again. “It’s more than just giving an injection, which at least requires a nurse to do it, and many outpatient programs in the community don’t have medical staff there to do it regularly,” he said. While methadone and buprenorphine are MATs that have been on the market for some time, Vivitrol is relatively new. John Brooks and the Atlantic County jail teamed up last summer to create the state’s first mobile methadone program for inmates. Oberman said they now offer inmates Vivitrol, but they haven’t yet had any takers.

WWW.AMETHYSTCARES.COM 336.674.9781 • 3610 N. ELM STREET, SUITE A • GREENSBORO, NC 27455

We envision a society that values and promotes mental health as an integral part of overall health within and across diverse communities so that individuals and their families are free from stigma and discrimination and can successfully realize their potential.

3610 N Elm street suite a • greensboro, nc 27455 | www.amethystcares.com

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32

Made with FlippingBook - Online Brochure Maker